Objective: To develop a more applicable approach that uses recipient-derived dendritic cells (DC) for organ transplantation. Summary Background Data: Systemic administration of immature donor DC that are deficient in costimulatory molecules delays the onset of allograft rejection. However, this approach requires in vitro DC propagation and would not be applicable to deceased donor organ transplantation. Methods: DC were propagated from C3H (H2 k ) mouse bone marrow with GM-CSF; their maturation was arrested by treatment with oligodeoxyribonucleotides (ODN) specifically against nuclear factor (NF)-B. The DC were pulsed with B10 (H2 b ) splenocyte lysate. DC phenotype was examined by flow cytometry. Their allostimulatory activity was assessed in vitro by MLR and CTL assays and in vivo by the influence on B10 cardiac allograft survival. Cytokine profiles were analyzed by ELISA and RNase protection assay. NF-B activity in DC nuclear protein was detected by gel shifting assay. Results: Compared with mature DC, NF-B ODN-treated immature DC pulsed with B10 (H2 b ) spleen cell lysate elicited markedly lower proliferative responses and correlated with reduced IFN-␥ and increased IL-10 production. In contrast to administration of mature C3H DC pulsed with B10 antigen that accelerated rejection of B10 cardiac allografts, a single injection of NF-B ODN DC pulsed with donor antigens significantly prolonged allograft survival in an antigen-specific manner. This was associated with induction of T-cell hyporesponsiveness and enhanced T-cell apoptosis. Conclusions: An approach to use recipient DC as a "vaccine" strategy provides a more feasible approach for deceased-donor organ transplantation. (Ann Surg 2005;241: 497-505) From the Thomas E.
T he ability of dendritic cells (DCs) to induce immunity or tolerance is related to their state of maturation. 1, 2 Mature DC express high levels of costimulatory molecules, secrete cytokines including IL-12, and stimulate vigorous T-helper (Th) 1 responses. In contrast, immature DCs (iDCs) express low levels of costimulatory molecules and induce antigenspecific hyporesponsiveness by triggering T-cell apoptosis 3 or inducing T regulatory cells. 4 It has been well established that intravenous injection of immature donor-derived DCs that are deficient in costimulatory molecules delays the onset of allograft rejection. A limitation to the approach of administering donor-derived iDCs to prevent allograft rejection is that DC propagation either from donor bone marrow (BM) or peripheral blood requires at least 5 to 6 days, 5 while decease donor organ transplantation is usually on a semiemergency basis. Thus, an approach using recipient-derived DCs as a means to immunomodulate recipient alloimmunity would be a more feasible approach for such transplants.
Maturation of DCs is associated with activation of the nuclear factor (NF)-B transcription factor, which induces expression of a variety of genes involved in inflammatory responses and costimulatory molecules. 6 NF-B is associated with inhibitor I-B in the cytoplasm as an inactive complex. Degradation of I-B allows translocation of the freed NF-B to the nucleus where it regulates target gene expression by binding to a specific DNA motif. We have constructed a decoy double-stranded oligodeoxynucleotide (ODN) containing consensus NF-B binding sites that inhibit NF-B activity. We have also demonstrated that N-FB ODNs are incorporated efficiently by DCs and specifically inhibit NF-B DNA-binding capacity. 7, 8 The NF-B ODNs selectively suppress costimulatory molecule expression without interfering with major histocompatibility complex (MHC) class I or II expression on DC. This is important, since expression of MHCs on DCs are required in the delivery of tolerogenic signals. 5 Modification with the NF-B ODN renders DCs resistant to maturation, eg, after being stimulated by LPS 7 or adenoviral vector transfection. 8 In addition, administration of in vitro modified donor-derived NF-B ODN DCs induces alloreactive T-cell hyporesponsiveness in experimental organ transplant models. 7 In this study, we propagated iDCs from recipient C3H mouse BM with GM-CSF whose maturation was arrested by NF-B ODN. Administration of these iDCs pulsed with donor spleen lysate significantly prolonged B10 allograft survival in C3H recipients in antigen-specific manner. This was associated with induction of specific T-cell hyporesponsiveness and apoptotic death.
MATERIALS AND METHODS

Mice
Male C57BL/10J (B10; H-2 b ), C3H/HeJ (C3H; H-2 k ) mice were purchased from the Jackson Laboratory, Bar Harbor, ME. They were maintained in the specific pathogenfree facility of the University of Pittsburgh. Animals were fed standard chow ad libitum and used at 8 to 12 weeks of age. The use and care of these animals was in accordance with institutional and National Institutes of Health guidelines.
ODNs
Double-stranded NF-B ODN decoys were generated using equimolar amounts of single-stranded sense and antisense phosphorothioate-modified oligonucleotides containing 2 NF-B binding sites (italic): 5Ј-AGGGACTTTCCGCT-GGGGACTTTCC-3Ј. 7 Sense and antisense strands of each oligonucleotide were mixed in the presence of 150-mM NaCl, heated to 100°C and allowed to cool to room temperature to obtain double-stranded DNA. Fluorescein isothiocyanate (FITC)-conjugated double-stranded decoys were prepared in a similar fashion.
DC Culture
BM cell suspensions were isolated from femurs of C3H mice and propagated in 24-well plates (2 ϫ 10 6 per well) in 2 mL RPMI-1640 medium (Life Technologies, Gaithersburg, MD) supplemented with antibiotics, 10% (vol/vol) fetal calf serum (referred to subsequently as complete medium) and 4 ng/mL mouse GM-CSF with or without 1000 U/ml rIL-4 (Schering-Plough, Kenilworth, NJ) for 5 to 7 days. Thus, 2 populations of predominantly GM-CSF-stimulated iDCs and GM-CSF plus IL-4-stimulated mature DC (mDC) were obtained. Those selection and purification procedures were similar to the ones previously reported. 3 To arrest iDC maturation, 10 M NF-B ODNs were added at the initiation of iDC culture. DCs were then washed twice with complete medium before use. For pulsing with donor antigens, B10 spleen cell lysate that was prepared by repeat freezing (5 minutes in dry ice-ethanol bath) and thawing (10 minutes in 37°C warm bath) 4 to 5 times, and added at 1/1, 1/5 or 1/10 of DC/spleen cell (used to prepare lysate) ratio for the last 48 hours of DC culture. C3H spleen cell lysate was used as control. The purity of DC preparations was routinely monitored by flow cytometric analysis using anti-CD11c mAb (BD PharMingen, San Diego, CA). DC preparations used in this study contained 85% to 90% CD11c ϩ cells.
Electrophoretic Mobility Shift Assay (EMSA)
Nuclear proteins were extracted from cells (2 ϫ 10 6 ) as described, 9 and either assayed immediately or stored at Ϫ80°C until further use. EMSA was performed using a commercially available kit (Promega, Madison, WI) that was supplied with an NF-B oligonucleotide (sense sequence: 5Ј-AGTTGAGGG-GACTTTCCCAGGC-3Ј) which was end-labeled with ␥-32 P-ATP (NEN, Boston, MA) and used as a probe according to the manufacturer's protocol. Nuclear proteins (1 g) were loaded in each lane. The mobility shift was detected by running the mixture on a 4% acrylamide gel. Shifted bands were visualized by autoradiography. For DNA competition, a 25-fold excess of unlabeled probe oligonucleotides (cold probe) was incubated in the binding reaction.
Flow Cytometry
Expression of cell surface antigens was analyzed by cytofluorography, using an EPICS ELITE flow cytometer (Coulter Corp, Hialeah, FL). Cells were stained with FITC or phycoerythrin (PE)-conjugated rat antimouse monoclonal antibodies (mAbs) for MHC class I, II, CD4, CD8, CD40, CD80, CD86 or CD11c after blocking nonspecific binding with 10% vol/vol normal serum. FITC-or PE-conjugated isotype-matched irrelevant mAbs were used as negative controls (all from BD PharMingen). After staining, the cells were fixed in 2% paraformaldehyde in isotonic saline before analysis.
Mixed Leukocyte Reactions (MLR)
One-way MLR culture was performed in triplicate in 96-well, round-bottom microculture plates (Corning, NY). Nylon wool-eluted spleen T cells (2 ϫ 10 5 /well) from C3H mice were used as responders. Graded doses of ␥-irradiated (20Gy; x-ray source) C3H BM-derived DCs pulsed with B10 spleen cell lysate were used as stimulators. DCs not pulsed with alloantigens were used as controls. Cultures were maintained in RPMI-1640 complete medium, for 3 to 5 days in 5% CO 2 in air. ͓ 3 H͔TdR (1 Ci/well) was added for the final 18 hours, and incorporation of ͓ 3 H͔TdR was assessed by liquid scintillation counting. Results were expressed as mean counts per minute (cpm) Ϯ 1 SD.
Heart Transplantation
Intraabdominal vascularized heart transplantation was performed as described. 10 Graft survival was assessed by daily transabdominal palpation. Cessation of heartbeat indicated rejection of the allograft, which was subsequently confirmed by histologic examination.
Cytokine Secretion
The cell culture supernatants were harvested and analyzed for the presence of cytokines using commercial ELISA kits (R & D Systems, Minneapolis, MN) according to the manufacturer's protocols. A standard curve using recombinant cytokine was generated for each assay.
Apoptosis Assay
The apoptotic T cells were identified by double staining with T cell surface markers and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL). The cells were fixed with 4% paraformaldehyde after staining with PE-conjugated rat antimouse mAb (anti-CD3, CD4 or CD8) and incubated for 1 hour at room temperature. The cells were washed with PBS and resuspended in permeabilization solution (0.1% Triton X-100 in 0.1% sodium citrate) for 2 minutes on ice. TUNEL reaction mixture (Roche, Mannheim, Germany) was then added. Ten percent goat serum was used to block the nonspecific binding. Cells incubated with label solution in the absence of terminal transferase were used as negative controls. Quantitative analysis was performed by flow cytometry, with 10,000 events acquired.
Statistical Analysis
The parametric data are presented as mean Ϯ 1 SD and statistical significance was determined by Student t test. Graft survival between groups of transplanted animals was compared using the log-rank test for comparison of survival curves. Values of P Ͻ 0.05 were considered statistically significant.
RESULTS
NF-B ODN Inhibits NF-B DNA Binding in DCs
To determine the inhibitory effect of NF-B ODNs on the NF-B binding capacity in DCs, nuclear proteins extracted from DCs propagated from BM of C3H mice in the presence of GM-CFS with or without NF-B ODN were assessed for NF-B DNA binding by EMSA. The specificity of NF-B binding was demonstrated by utilizing both consensus NF-B probes and unlabeled NF-B probes (cold probe) as a competitor. As shown in Figure 1 
DC Phenotype
DCs propagated from C3H BM cells in the presence of GM-CSF and IL-4 demonstrated mature DC phenotype with high MHC class I and II antigens, as well as costimulatory molecules (Fig. 2) , as previous reported. 3, 10 Pulsing with alloantigens (B10 spleen cell lysate) did not alter expression of these molecules on mDCs (Fig. 2 ). On the other hand, NF-B ODN iDCs expressed low costimulatory molecules and MHC class II antigens. The percentage of iDCs expressing MHC class I, II increased following pulsing with alloantigens, but there was no change in costimulatory molecule (CD40, CD80 and CD86) expression on NF-B ODN iDCs (Fig. 2) . In contrast, expression of CD40 and CD80 in iDCs not treated with NF-B ODN markedly increased following B10 alloantigen pulsing (incidence of CD40 ϩ from 29 to 55%, CD80 ϩ from 32 to 53%, data not shown), suggesting that iDCs not treated with NF-B ODN have an unstable immature phenotype. These data indicate that competitive inhibition of NF-B by NF-B ODN can prevent costimulatory molecule up-regulation on iDCs upon alloantigen stimulation and retain a stable immature phenotype.
NF-B ODN iDCs Stimulate Minimal T-Cell Proliferative Responses
As shown in Figure 3A , C3H BM-derived mDCs pulsed with B10 spleen cell lysate effectively presented B10 alloantigens through the indirect pathway, resulting in markedly proliferative responses in C3H-naive T cells in an MLR assay (P Ͻ 0.05, B10 ͓allogeneic͔ antigen-pulsed groups compared with any C3H ͓syngeneic͔ antigen-pulsed group). To assess optimal capacity to achieve maximal stimulation of proliferative responses in naive T cells, various ratios of DC:spleen cells for antigen pulsing were analyzed. The differences were not significant between alloantigen pulsing groups (P Ͼ 0.05); however, the DC:spleen cell ratio of 1:5 for alloantigen pulsing was used in the following studies, unless otherwise indicated. We next examined the influence of NF-B ODN on indirect antigen-presenting activity of DCs. In contrast to alloantigen-pulsed mDCs and iDCs without NF-B ODN, both of which stimulated profound proliferative responses in syngeneic T cells (P Ͻ 0.05 compared with any other group), NF-B ODN iDCs pulsed with allogeneic antigens failed to induce T-cell proliferation in either 3-, 4-, or 5-day MLR (P Ͼ 0.05 compared with nonantigenpulsed groups, Fig. 3B ).
Influence of NF-B ODN iDC on T-Cell Cytokine Production
To examine the effect of DC on T-cell activation and differentiation, IFN-␥ and IL-10 levels in the supernatant of 3-day MLR culture were determined using ELISA. mDCs pulsed with B10 antigens elicited high IFN-␥ but low IL-10 production in syngeneic T cells, while T cells after stimulation by NF-B ODN iDC produced very low IFN-␥ but high levels of IL-10 (both P Ͻ 0.05, compared with the normal DC group, Fig. 3C ).
Systemic Administration of NF-B ODN iDCs Prolongs Cardiac Allograft Survival
Our ultimate goal was to assess the potential application of recipient-derived DC in prevention of allograft rejection. To address this, 2 ϫ 10 6 C3H NF-B ODN iDCs or mDCs pulsed with B10 alloantigens were intravenously injected into C3H recipients 7 days prior to receiving a B10 heart allograft in the absence of immunosuppressive therapy (administration of DC on d7-10 pretransplant has been shown to be the optimal time to affect the allograft survival). 11 Compared with the control group receiving no DC pretreatment (median survival time ͓MST͔ 10 days, n ϭ 8), pretreatment with mDCs significantly accelerated B10 heart allograft rejection (MST 7 days, n ϭ 7, P Ͻ 0.05). In contrast, administration of NF-B ODN iDCs markedly prolonged survival of cardiac allografts (MST 32, n ϭ 9, P Ͻ 0.01), with 3 grafts surviving 92, 95, and 98 days, respectively. The prolongation of allograft survival by NF-B ODN iDCs appeared to be antigen-specific, as administration of NF-B ODN iDCs pulsed with third-party (BALB/c) spleen cell lysate did not prolong survival of B10 cardiac grafts (n ϭ 7, P Ͼ 0.05 compared with the no-DC-treatment group, Fig. 4 ).
Administration of NF-B ODN iDCs Induces T-Cell Hyporesponsiveness
To examine the influence of in vivo administration of alloantigen-pulsed NF-B ODN iDCs on T cell responses, T cells isolated from spleens and/or mesenteric lymph nodes 1 week after DC treatment were assessed for their proliferative responses in MLR. T cells from C3H mice receiving mDCs pulsed with B10 antigens demonstrated markedly proliferative response upon ex vivo alloantigen stimulation (Fig. 5A ). On the other hand, T cells from NF-B ODN iDC-treated group exhibited significantly lower proliferative responses to alloantigen stimulation ( Fig. 5A , P Ͻ 0.05, compared with B10 antigen-pulsed mDC group). IFN-␥ levels in the supernatant of cultures were significantly decreased in T cells isolated from the animals administered with antigen-pulsed NF-B ODN iDCs compared with that from alloantigenpulsed mDCs (Fig. 5B ). Apoptotic cell death in both CD4 ϩ and CD8 ϩ T-cell populations from mice receiving antigenpulsed NF-B ODN iDCs was markedly higher than the T cells from those treated with antigen-pulsed mDCs, as assessed by TUNEL staining (Fig. 5C ).
DISCUSSION
There are direct and indirect pathways of allorecognition, both of which have been postulated to have roles in allograft immunity. In the direct pathway, recipient T cells 
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Recipient-Derived Immature DCs Prolong Allograft Survival directly interact with allogeneic MHC molecules on the donor APC of the allograft. In the indirect pathway, donor antigens are endocytosed by recipient APC, broken down to peptides, and then presented to T cells in the context of recipient MHC. T cells activated by either the direct or indirect pathway can initiate allograft rejection. Thus, both donor and recipient APCs mediate the rejection of transplanted allografts. 12, 13 We 3,10 and other investigators 14 have previously shown that administration of donor-derived DCs deficient in costimulatory molecules can suppress T-cell responses to transplanted allografts both in vitro and in vivo via the direct antigen presentation. It has been postulated that early acute allograft rejection is predominantly mediated by this pathway, since the allograft contains a significant number of donor-derived passenger APCs (particularly DCs), which present a high density of donor MHC molecules and can provide the necessary costimulatory signals to recipient T cells. However, the influence of the direct antigen presentation may diminish over time. 15, 16 In contrast, the indirect pathway will remain intact, such that the indirect alloresponse may be an important threat to long-term graft survival and may also facilitate chronic rejection. 17 The present study addressed the hypothesis of whether administration of recipient-derived DC deficient in costimulation is capable of inducing specific T-cell hyporesponsiveness via the indirect antigen-presenting pathway. We attempted to achieve this goal by using protocols to administer recipient-derived iDCs treated with NF-B ODN, which would allow the DCs to retain a stable immature phenotype even in the presence of strong maturational stimuli. 7, 8 The data generated in this study demonstrated that a single injection of NF-B ODN iDCs propagated from recipient BM and pulsed with donor antigens can specifically delay vascularized heart allograft rejection by inducing donor antigenspecific T-cell hyporesponsiveness. Such an approach would potentially be more feasible to use in clinical transplantation when compared with the generation of DCs from cadaveric donors. In addition, indirect allorecognition is usually directed toward a certain, but limited, number of immunodominant MHC determinants 18 ; therefore, the results of this study suggest that the induction of hyporesponsiveness to a single or few determinants recognized by T cells through the indirect pathway may be able to significantly prolong allograft survival. Indeed, investigators have shown the data that utilization of peptide analogues of the allopeptide can induce hyporesponsiveness in T cells and prevent allograft rejection in vivo with inhibition of indirect alloreactivity. 19 As shown in Figure 4 , DC pulsed with BALB/c spleen cell lysate failed to prolong B10 allograft survival, although B10 and BALB/c share some minor histocompatibility complex (mHC) antigens, indicating that indirect presentation of donor mHC antigens by recipient ODN DCs may not prolong allograft survival in this experimental model. Taken together, these results suggest a possible methodology for the use of recipient-derived DCs that are pulsed with synthesized allopeptides, namely, that a regimen using DC pretreatment can easily be employed in cadaveric organ transplants without the logistic limitations inherent in timing of immunomodulation protocols. Moreover, current clinically available immunosuppressive agents do not effectively prevent indirect allorecognition. 20 Thus, achieving transplant hyporesponsiveness via the delivery of an inhibitory signal by administration of recipient DCs targeted to the indirect pathway may provide a useful approach to development of the novel immunosuppression strategies in organ transplantation. Recent studies also indicate that T-cell recognition of processed alloantigens (allopeptides) presented by recipients APCs through the indirect pathway of allorecognition plays a critical role in the development and progression of chronic rejection. [21] [22] [23] It stands to reason that devising novel strategies for the induction of tolerance in T cells with indirect allospecificity, as 
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Annals of Surgery • Volume 241, Number 3, March 2005 proposed in this study, may be a strategy to prevent chronic rejection and prolong the lifespan of organ allografts. 24 We previously reported that tolerogenic DCs can be obtained by propagation of DCs in the presence of suppres-sive cytokines, such as TGF-␤. 5 The immunosuppressive effect of the TGF-␤-induced iDCs is, however, limited due to their subsequent activation in vivo after exposure to an allogeneic and inflammatory environment. 5 Adenoviral vec- 
Annals of Surgery • Volume 241, Number 3, March 2005
Recipient-Derived Immature DCs Prolong Allograft Survival tors were next used in an attempt to transduce immunosuppressive genes, such as IL-10, TGF␤, CTLA4Ig, into DCs. However, transgene expression of down-regulatory molecules is surmounted by the up-regulation of costimulatory molecules induced by stimulation of the adenoviral vectors themselves. 25, 26 NF-B activation plays a pivotal role in DC maturation and activation since many inducible genes encoding cytokines, chemokines, cell adhesion molecules, growth factors, costimulatory molecules (CD80, CD86), and immune receptors contain NF-B binding sites in their promoter or enhancer region. 27 Mature DCs express high levels of NF-B, and mice lacking NF-B complexes fail to develop mature myeloid-derived DCs. 28, 29 Lipopolysaccharide (LPS)induced maturation of mouse splenic DCs is dependent on activation of NF-B. 6 Thus, the strategy of blocking NF-B binding to its cognate sequences at promoter regions by antisense ODN to inhibit DC maturation was employed. Our results revealed that NF-B ODN iDCs propagated from recipient BM cells expressed low levels of costimulatory molecules, including CD40, CD80, and CD86, which were not up-regulated upon pulsing with alloantigens. Our previous data have also demonstrated that NF-B ODN DC are resistant to LPS-induced maturation. 7 The induction of hyporesponsiveness requires expression of antigen in the context of MHC molecules and the absence of costimulation on APCs. NF-B ODN iDCs are well suited for this function because they express relatively high levels of MHC, with diminished expression of the surface markers CD40, CD80, and CD86. These results indicate that a stable immature phenotype can be achieved employing this approach. This is critical because DC maturation is a process associated with loss of antigen-capturing ability but increased costimulatory capacity for T-cell activation and thus can more effectively participate in the indirect priming of host alloreactive T cells. 30 In contrast to alloantigen-pulsed mDCs and iDCs that stimulated vigorous T cell responses in vitro, NF-B ODN iDCs (despite pulsing of alloantigens) induced very low T-cell proliferative responses. This was unlikely due to a failure of T-cell cross-priming, as T cells stimulated by antigen-pulsed NF-B ODN iDCs were able to induce production of large amounts of IL-10 by syngeneic T cells. The mechanism(s) whereby administration of recipientderived NF-B ODN iDCs prolongs cardiac allograft survival is at present not completely understood. Our ex vivo data suggest that induction of specific T cell hyporesponsiveness is associated with inhibition of IFN-␥ secretion. NF-B ODN iDCs also enhance apoptosis in both CD4 ϩ and CD8 ϩ T-cell populations, implying that the prolongation of cardiac allografts may be attributed to induction of apoptosis of activated T cells in the grafts and host lymphoid organs. These findings are consistent with our previous observations that, following administration of donor-derived iDCs, T-cell hyporesponsiveness was associated with marked enhancement of the apoptotic cell death of the responder T cells. 31 Our data are also consistent with the observations in "cross-tolerance" that occurs through indirect presentation. The cross-presentation has been shown to engage a well-defined pathway of antigen-induced T-cell death, resulting in deletion of T cells responding to the antigens. 18, 30, 32 Apoptosis of alloreactive T cells has been shown to be an important mechanism in induction of organ transplant tolerance. 33, 34 It appears that after donor-antigen-pulsed recipient-derived DCs engineered by NF-B ODN home to recipient lymphoid tissue, the negative signals are delivered to T cells by indirect presentation of allopeptides, resulting in induction of alloreactive T-cell apoptotic death.
In summary, we have shown that a single injection of recipient-derived DCs pulsed with alloantigens, whose maturation is arrested by NF-B ODN, significantly prolongs cardiac allograft survival in an alloantigen-specific manner. This approach induces specific systemic T-cell hyporesponsiveness via the indirect alloantigen recognition pathway. The mechanism(s) responsible may involve enhanced apoptotic death of alloreactive T cells. This novel pretreatment regimen by using iDCs derived from recipients provides an alternative approach that enhances the clinical applicability and may also serve to induce a more comprehensive immunosuppression.
